Biodesix, Inc. (BDSX)

USD 0.52

(-1.52%)

Total Liabilities Summary of Biodesix, Inc.

  • Biodesix, Inc.'s latest annual total liabilities in 2023 was 94.51 Million USD , up 30.73% from previous year.
  • Biodesix, Inc.'s latest quarterly total liabilities in 2024 Q3 was 74.88 Million USD , down -5.9% from previous quarter.
  • Biodesix, Inc. reported annual total liabilities of 72.3 Million USD in 2022, up 28.26% from previous year.
  • Biodesix, Inc. reported annual total liabilities of 56.37 Million USD in 2021, down -29.45% from previous year.
  • Biodesix, Inc. reported quarterly total liabilities of 79.58 Million USD for 2024 Q2, down -14.15% from previous quarter.
  • Biodesix, Inc. reported quarterly total liabilities of 92.7 Million USD for 2024 Q1, down -1.92% from previous quarter.

Annual Total Liabilities Chart of Biodesix, Inc. (2023 - 2018)

Historical Annual Total Liabilities of Biodesix, Inc. (2023 - 2018)

Year Total Liabilities Total Liabilities Growth
2023 94.51 Million USD 30.73%
2022 72.3 Million USD 28.26%
2021 56.37 Million USD -29.45%
2020 79.9 Million USD -70.42%
2019 270.17 Million USD 13.95%
2018 237.08 Million USD 0.0%

Peer Total Liabilities Comparison of Biodesix, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD -134.962%
Applied DNA Sciences, Inc. 8.77 Million USD -976.594%
Aspira Women's Health Inc. 8.62 Million USD -995.584%
BioNexus Gene Lab Corp. 1.74 Million USD -5325.901%
bioAffinity Technologies, Inc. 3.36 Million USD -2707.714%
bioAffinity Technologies, Inc. 3.36 Million USD -2707.714%
Bionano Genomics, Inc. 118.24 Million USD 20.069%
CareDx, Inc 223.28 Million USD 57.671%
Check-Cap Ltd. 1.33 Million USD -7006.466%
Castle Biosciences, Inc. 86.54 Million USD -9.214%
DarioHealth Corp. 38.24 Million USD -147.133%
Exact Sciences Corporation 3.32 Billion USD 97.158%
Fulgent Genetics, Inc. 139.82 Million USD 32.403%
Guardant Health, Inc. 1.62 Billion USD 94.193%
ICON Public Limited Company 7.74 Billion USD 98.78%
IDEXX Laboratories, Inc. 1.77 Billion USD 94.676%
Illumina, Inc. 4.36 Billion USD 97.835%
Intelligent Bio Solutions Inc. 5.59 Million USD -1589.091%
iSpecimen Inc. 6.07 Million USD -1455.036%
Standard BioTools Inc. 159.86 Million USD 40.878%
MDxHealth SA 121.92 Million USD 22.48%
23andMe Holding Co. 206.64 Million USD 54.262%
Medpace Holdings, Inc. 1.09 Billion USD 91.391%
Myriad Genetics, Inc. 312.9 Million USD 69.794%
Mainz Biomed B.V. 12.15 Million USD -677.282%
ENDRA Life Sciences Inc. 1.09 Million USD -8530.361%
NeoGenomics, Inc. 739.69 Million USD 87.222%
Neogen Corporation 1.44 Billion USD 93.436%
Inotiv, Inc. 588.04 Million USD 83.927%
Natera, Inc. 691.79 Million USD 86.338%
OPKO Health, Inc. 622.47 Million USD 84.816%
Psychemedics Corporation 6.59 Million USD -1332.495%
Prenetics Global Limited 44.01 Million USD -114.744%
Prenetics Global Limited 44.01 Million USD -114.744%
Precipio, Inc. 3.67 Million USD -2473.965%
Personalis, Inc. 95.65 Million USD 1.194%
RadNet, Inc. 2.07 Billion USD 95.441%
Sera Prognostics, Inc. 25.28 Million USD -273.832%
Sotera Health Company 2.68 Billion USD 96.482%
Neuronetics, Inc. 81.64 Million USD -15.77%
Star Equity Holdings, Inc. 21.67 Million USD -336.06%
Star Equity Holdings, Inc. 21.67 Million USD -336.06%
Trinity Biotech plc 83.38 Million USD -13.35%
Twist Bioscience Corporation 152.97 Million USD 38.213%
Exagen Inc. 34.25 Million USD -175.959%